ResMed Inc (RMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ResMed Inc (RMD) has a cash flow conversion efficiency ratio of 0.085x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($554.13 Million) by net assets ($6.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ResMed Inc (RMD) net asset quality to measure how much of total assets are equity-financed.
ResMed Inc - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how ResMed Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ResMed Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
ResMed Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ResMed Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NARI Technology Co Ltd
SHG:600406
|
0.034x |
|
GE HealthCare Technologies Inc.
NASDAQ:GEHC
|
0.027x |
|
SEVEN+I HLDGS UNSP.ADR1/2
F:S6MA
|
0.073x |
|
Eternal Limited
NSE:ETERNAL
|
-0.003x |
|
RYANAIR HLDGS ADR NEW/5
F:RY4D
|
-0.008x |
|
Huaneng Lancang River Hydropower Inc Class A
SHG:600025
|
0.071x |
|
COSCO SHIPPING Holdings Co Ltd
SHG:601919
|
0.022x |
|
SHINHAN FINL ADR/1 SW5000
F:KSF1
|
-0.082x |
Annual Cash Flow Conversion Efficiency for ResMed Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of ResMed Inc from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see ResMed Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $5.97 Billion | $1.75 Billion | 0.294x | +1.88% |
| 2024-06-30 | $4.86 Billion | $1.40 Billion | 0.288x | +71.61% |
| 2023-06-30 | $4.13 Billion | $693.30 Million | 0.168x | +60.67% |
| 2022-06-30 | $3.36 Billion | $351.15 Million | 0.104x | -59.07% |
| 2021-06-30 | $2.89 Billion | $736.72 Million | 0.255x | -20.54% |
| 2020-06-30 | $2.50 Billion | $802.25 Million | 0.321x | +45.03% |
| 2019-06-30 | $2.07 Billion | $459.05 Million | 0.222x | -9.68% |
| 2018-06-30 | $2.06 Billion | $505.03 Million | 0.245x | +16.12% |
| 2017-06-30 | $1.96 Billion | $414.05 Million | 0.211x | -34.67% |
| 2016-06-30 | $1.69 Billion | $547.93 Million | 0.323x | +33.92% |
| 2015-06-30 | $1.59 Billion | $383.18 Million | 0.241x | +8.48% |
| 2014-06-30 | $1.76 Billion | $391.27 Million | 0.223x | -11.03% |
| 2013-06-30 | $1.61 Billion | $402.82 Million | 0.250x | +4.94% |
| 2012-06-30 | $1.61 Billion | $383.16 Million | 0.238x | +45.66% |
| 2011-06-30 | $1.73 Billion | $283.19 Million | 0.164x | +11.93% |
| 2010-06-30 | $1.29 Billion | $188.21 Million | 0.146x | -31.76% |
| 2009-06-30 | $1.12 Billion | $238.88 Million | 0.214x | +68.11% |
| 2008-06-30 | $1.08 Billion | $137.84 Million | 0.127x | +30.24% |
| 2007-06-30 | $931.22 Million | $91.11 Million | 0.098x | -27.07% |
| 2006-06-30 | $738.15 Million | $99.03 Million | 0.134x | -10.52% |
| 2005-06-30 | $474.06 Million | $71.08 Million | 0.150x | -29.19% |
| 2004-06-30 | $361.50 Million | $76.54 Million | 0.212x | +2.30% |
| 2003-06-30 | $286.43 Million | $59.28 Million | 0.207x | +12.04% |
| 2002-06-30 | $192.93 Million | $35.64 Million | 0.185x | -37.19% |
| 2001-06-30 | $100.37 Million | $29.52 Million | 0.294x | +36.32% |
| 2000-06-30 | $93.97 Million | $20.27 Million | 0.216x | -15.11% |
| 1999-06-30 | $71.61 Million | $18.20 Million | 0.254x | +89.87% |
| 1998-06-30 | $50.80 Million | $6.80 Million | 0.134x | -37.16% |
| 1997-06-30 | $44.60 Million | $9.50 Million | 0.213x | +137.35% |
| 1996-06-30 | $39.00 Million | $3.50 Million | 0.090x | +270.51% |
| 1995-06-30 | $28.90 Million | $700.00K | 0.024x | -91.52% |
| 1994-06-30 | $5.60 Million | $1.60 Million | 0.286x | -17.14% |
| 1993-06-30 | $2.90 Million | $1.00 Million | 0.345x | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more